Skip to main content
. 2020 May 26;10:8739. doi: 10.1038/s41598-020-65166-y

Table 1.

Melatonin/ Placebo groups’ demographics.

Demographics Melatonin Placebo
N = 30 N = 30
Sex (n,%)
Male 23, 76.7% 23, 76.7%
Female 7, 23.3% 7, 23.3%
Age range
19–25 0, 0.0% 1, 3.3%
26–40 10, 33.3% 11, 36.7%
41–60 16, 53.3% 17, 56.7%
>60 4, 13.3% 1, 3.3%
Marital status
Single 14, 46.7% 17, 56.7%
Married 3, 10.0% 7, 23.3%
Divorced/separated 12, 40.0% 6, 20.0%
Widowed 1, 3.3% 0, 0.0%
Employment
Full time (>35 hr/wk) 4, 13.3% 7, 23.3%
Short-term disability 3, 10.0% 3, 10.0%
Self-employed 3, 10.0% 3, 10.0%
Welfare 3, 10.0% 0, 0.0%
Student 1, 3.3% 1, 3.3%
Part time(<35 hr/wk) 1, 3.3% 4, 13.3%
Long-term disability 3, 10.0% 3, 10.0%
Not employed 7, 23.3% 10, 33.3%
Retired 5, 16.7% 0, 0.0%
Highest completed education
Part of high school 0, 0.0% 2, 6.7%
High school 10, 33.3% 6, 20.0%
College 12, 40.0% 7, 23.3%
University 7, 23.3% 14, 46.7%
Graduate degree 1, 3.3% 1, 3.3%
Ethnicity
Black or African American 1, 3.3% 1, 3.3%
Asian 0, 0.0% 1, 3.3%
Caucasian 24, 80.0% 21, 70.0%
Mixed races 5, 16.7% 7, 23.3%
Smokers 16, 53.3% 14, 46.7%
Non smokers 14, 46.7% 16, 53.3%
AUD severity
Mild (2-3) 1, 3.3% 1, 3.3%
Moderate (4-5) 2, 6.7% 1, 3.3%
Severe (>6) 27, 90.0% 28, 93.3%
BDI mean at baseline (±SD) 16.30 (7.05) 18.47 (9.64)
BAI mean at baseline (±SD) 14.53 (10.08) 16.33 (12.20)
AUDIT score mean at baseline (±SD) 24.53 (8.67) 27.13 (7.99)
Global PSQI score mean baseline (±SD) 12.97 (2.28) 11.70 (3.37)